Cardiometabolic Health Congress (CMHC) | VuMedi

Cardiometabolic Health Congress (CMHC)

Cardiometabolic Health Congress (CMHC)

The global epidemic of metabolic syndrome, a constellation of cardiometabolic risk factors, and that of obesity, type 2 diabetes, atherosclerosis, chronic kidney disease, cardiovascular disease, and NAFLD/NASH, have become the modern-day health hazard across the world. Lifestyle factors, including a lack of physical activity and proper nutrition, as well as ...
read more ↘ smoking, can further exacerbate the impacts of cardiometabolic risk or disease, which is showing no signs of slowing down. Overall, the numbers are particularly striking. There are more than 463 million adults living with diabetes worldwide, and the number is expected to rise to more than 700 million by 2045.1 Furthermore, 232 million have undiagnosed diabetes with an additional 374 million having prediabetes.1 The increasing prevalence of overweight and obesity (now estimated to affect 2 billion adults, or nearly 30% of the world population), high cholesterol (>40% of the world’s population), and hypertension (>1 billion), together with type 2 diabetes (T2D), are some of the major drivers of morbidity and mortality worldwide.2-4 They affect multiple organ systems, including the heart, liver, and kidneys, spanning several disease domains and outcomes.

Although clinicians are learning more about the interconnections between these conditions and risk factors, the application of these principles to patient care remains in its infancy. As these diseases and risk factors exist in a continuum, they cannot be treated in silos, which is unfortunately what tends to happen in clinical practice. The Cardiometabolic Health Congress (CMHC) has been at the forefront of looking at the whole spectrum of cardiometabolic disease, including obesity, diabetes, lipids, hypertension, cardio-renal disease, and practical ways to address them. Through our live conferences and extensive online education platforms, we strive to synthesize and translate the latest cutting-edge medical research into practical clinical strategies for preventing, delaying, diagnosing, treating, and managing the whole spectrum of cardiometabolic disorders. The goal is to provide the medical community with evidence-based interventions that they can apply immediately in clinical practice to improve health outcomes and quality of life for the growing numbers of patients at increased cardiometabolic risk.
↖ read less

Cardiometabolic Risk in Children and Adolescents

Cardiometabolic Health Congress (CMHC)

T2D in Youth: What Are the Developmental Origins?

FEATURING Dana Dabelea

200 views
March 25, 2021

Cardiometabolic Health Congress (CMHC)

Target Organ Damage Related to Cardiometabolic Disease In Children and Adolescents: How Do They Relate Specifically to the Cardiovascular System?

FEATURING Stephen Daniels

97 views
March 25, 2021

Cardiometabolic Health Congress (CMHC)

Youth Onset T2D: What Are the Incidence And Prevalence Rates? What Are the Projections?

FEATURING Dana Dabelea

177 views
March 24, 2021
1

Cardiometabolic Health Congress (CMHC)

T2D Developing in Youth: What Are the Driving Factors Behind This Aggressive Disease? What Have We Learned From the RISE Study?

FEATURING Dana Dabelea

206 views
March 24, 2021

Cardiometabolic Health Congress (CMHC)

The Upward Trend of Youth Onset T2D: What Are the Standards of Care?

FEATURING Dana Dabelea

169 views
March 24, 2021

Cardiometabolic Health Congress (CMHC)

The Rise of Pediatric Non-Alcoholic Fatty Liver Disease: What Are the Methods For Screening?

FEATURING Stavra Xanthakos

322 views
March 24, 2021
2

Cardiometabolic Health Congress (CMHC)

Pediatric NAFLD: What Are the Interventions? What Makes Treatment So Challenging?

FEATURING Stavra Xanthakos

190 views
March 24, 2021

Cardiometabolic Health Congress (CMHC)

Comprehensive Treatment of Cardiometabolic Risk in Pediatric Population: Cases, Panel Discussion, Q&A

FEATURING Joshua Samuels, Sarah De Ferranti, Stavra Xanthakos, Stephen Daniels

22 views
March 24, 2021

Cardiometabolic Health Congress (CMHC)

Hypertension in Children and Adolescents: When and How to Properly Measure BP in Children? What Are the New Thresholds for Determining Hypertension?

FEATURING Joshua Samuels

978 views
March 19, 2021
10

Cardiometabolic Health Congress (CMHC)

Pediatric Dyslipidemia: What Is the Frequency? What Are the Differences Between Inherited vs. Acquired Lipid Disorders?

FEATURING Sarah De Ferranti

214 views
March 19, 2021
2

Cardiometabolic Health Congress (CMHC)

Dyslipidemia in Pediatric Patients: How Is It Identified? What Are the Treatment Options?

FEATURING Sarah De Ferranti

216 views
March 19, 2021

Cardiometabolic Health Congress (CMHC)

Addressing Cardiometabolic Risk in Children and Adolescents: What Is Cardiometabolic Burden?

FEATURING Elaine Urbana

133 views
March 19, 2021

Cardiometabolic Health Congress (CMHC)

The Big Picture of Obesity and Metabolic Syndrome in the Pediatric Population: How is Obesity Defined in Children? How Has Prevalence Changed Over Time?

FEATURING Jessica Woo

442 views
March 19, 2021
1

Cardiometabolic Health Congress (CMHC)

Obesity and Metabolic Syndrome in the Pediatric Population: What Are the Long-Term Consequences? What Are the Guidelines For Screening and Treatment?

FEATURING Jessica Woo

190 views
March 19, 2021
1

Cardiometabolic Health Congress (CMHC)

Cardiometabolic Burden in Children: What Are the Risk Factors? How Do Risk Factors in Childhood Influence Risk Factors During Adulthood?

FEATURING Carissa Baker-Smith

16 views
March 19, 2021

Cardiometabolic Health Congress (CMHC)

Pediatric Obesity and Cardiometabolic Syndrome: How Do We Promote and Achieve Lifestyle Interventions?

FEATURING Carissa Baker-Smith

239 views
March 19, 2021
3

Cardiometabolic Health Congress (CMHC)

Treating Pediatric Obesity: What Are the Limitations of Lifestyle Therapy?

FEATURING Aaron Kelly

18 views
March 19, 2021

Cardiometabolic Health Congress (CMHC)

Pharmacotherapy and Bariatric Surgery as Treatment for Pediatric Obesity: What Is the Rationale For the Use of Adjunctive Treatments?

FEATURING Aaron Kelly

158 views
March 19, 2021
1

Cardiometabolic Health Congress (CMHC)

Case Discussion: What Decisions, Successes, and Challenges Were Experienced While Treating Pediatric Obesity and Cardiometabolic Burden?

FEATURING Elaine Urbana, Jessica Woo, Carissa Baker-Smith, Aaron Kelly

144 views
March 19, 2021